Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
- ILa | -.--% |
|
-2,55% | -3,73% |
10/07 | Esteve Healthcare S.L. ha completato l'acquisizione di HRA Pharma Rare Diseases America, LLC da Perrigo Company plc. | CI |
13/06 | PERRIGO COMPANY PLC : Piper Sandler rimane Buy | ZM |
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Consumer Self-Care Americas
63,6
%
| 2 926 | 65,7 % | 2 962 | 63,6 % | +1,24% |
Consumer Self-Care International
36,4
%
| 1 526 | 34,3 % | 1 693 | 36,4 % | +10,99% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
62,7
%
| 2 870 | 64,5 % | 2 917 | 62,7 % | +1,63% |
Europe
34,0
%
| 1 445 | 32,5 % | 1 582 | 34,0 % | +9,46% |
All Other Countries
2,5
%
| 107 | 2,4 % | 116 | 2,5 % | +8,39% |
Ireland
0,9
%
| 29 | 0,7 % | 41 | 0,9 % | +39,25% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 55 | 30/06/23 | |
Eduardo Bezerra
DFI | Director of Finance/CFO | 49 | 16/05/22 |
Alison Ives
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/15 |
Grainne Quinn
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/01/14 |
Ronald Janish
COO | Chief Operating Officer | 58 | 01/01/03 |
Chief Tech/Sci/R&D Officer | 66 | 01/10/06 | |
Bradley Joseph
IRC | Investor Relations Contact | - | - |
Adrian Innergård
PRN | Corporate Officer/Principal | 44 | - |
Corporate Officer/Principal | 55 | 11/09/23 | |
Robert Willis
HRO | Human Resources Officer | 55 | 01/05/13 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Orlando Ashford
CHM | Chairman | 55 | 15/12/20 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 06/02/17 |
Bradley Alford
BRD | Director/Board Member | 67 | 06/02/17 |
Donal O'Connor
BRD | Director/Board Member | 73 | 01/11/14 |
Geoffrey Parker
BRD | Director/Board Member | 59 | 07/11/16 |
Director/Board Member | 61 | 02/05/17 | |
Katherine Doyle
BRD | Director/Board Member | 56 | 29/07/20 |
Chief Executive Officer | 55 | 30/06/23 | |
Julia Brown
BRD | Director/Board Member | 54 | 01/11 |
Director/Board Member | 60 | 30/07/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 136 320 433 | 135 858 122 ( 99,66 %) | 0 | 99,66 % |
Coordinate società
![Indirizzo Perrigo Company plc(PRGO)](https://cdn.zonebourse.com/static/address/56537210.png)
Società del gruppo
Nome | Categoria e settore |
---|---|
Rosemont Pharmaceuticals Ltd.
![]() Rosemont Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rosemont Pharmaceuticals Ltd. develops, manufactures, and supplies oral liquid medicines. Its product categories include anaesthesia, cardiovascular system, central nervous system, endocrine system, gastro-intestinal system, infections malignant disease and immunosuppression, musculoskeletal and joint disease, nutrition and blood, and PEG/NG tube administration guides. The company was founded in 1967 and is headquartered in Leeds, the United Kingdom. |
Pharmaceuticals: Major
|
Omega Pharma Belgium NV
![]() Omega Pharma Belgium NV Medical DistributorsDistribution Services Part of Perrigo Co. Plc, Omega Pharma Belgium NV is a Belgian pharmaceutical company that supplies pharmaceuticals. The company is based in Nazareth, Belgium. The company was founded in 1977. Christophe van Damme has been the CEO of the company since 2020. |
Medical Distributors
|
Perrigo Israel Pharmaceuticals Ltd.
![]() Perrigo Israel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Perrigo Israel Pharmaceuticals Ltd. develops and markets generic products, pharmaceutical ingredients, novel dermatological products, and consumer products. The firm operates manufacturing facilities in the United States, Israel, United Kingdom, Mexico, and Germany. The company was founded in 1983 and is headquartered in Bnei Braq, Israel |
Pharmaceuticals: Major
|
Perrigo Investments LLC
![]() Perrigo Investments LLC Financial ConglomeratesFinance Part of Perrigo Co. Plc, Perrigo Investments LLC functions as an investment holding American company. |
Financial Conglomerates
|
Perrigo Israel Agencies Ltd.
![]() Perrigo Israel Agencies Ltd. Medical DistributorsDistribution Services Part of Perrigo Co. Plc, Perrigo Israel Agencies Ltd. is an Israeli company that distributes pharmaceutical products. The company is based in Bnei Braq, Israel. |
Medical Distributors
|
Elan Finance Plc
|
Finance/Rental/Leasing
|
Omega Pharma Capital NV
![]() Omega Pharma Capital NV Financial ConglomeratesFinance Part of Perrigo Co. Plc, Perrigo Capital NV is a company that focuses on encouraging Belgian patients to take proactive control of their health in partnership with pharmacists as central care providers. The company is based in Nazareth, Belgium. The company is brand builders at Perrigo Belgium, placing the Belgian patient at the center of everything they do and creating demand by addressing the patient's needs in a relevant and engaging manner. The company aims to make lives better by bringing quality, affordable self-care products that consumers trust wherever they are sold. The company was founded in 1987, and the CEO is Barbara de Saedeleer. |
Financial Conglomerates
|
Galpharm International Ltd.
![]() Galpharm International Ltd. Pharmaceuticals: MajorHealth Technology Galpharm International Ltd. manufactures and supplies over-the-counter and branded medicines. The company was founded on February 24, 1981 and is headquartered in Braunton, the United Kingdom. |
Pharmaceuticals: Major
|
Habsont Unlimited Co.
![]() Habsont Unlimited Co. Finance/Rental/LeasingFinance Part of Perrigo Co. Plc, Habsont Unlimited Co. provides financial leasing services. The company is based in Dublin, Ireland and was founded in 2013. |
Finance/Rental/Leasing
|
Settore
Vendite per attività
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+60,25% | 846 Mrd | |
+38,56% | 628 Mrd | |
-4,49% | 360 Mrd | |
+18,30% | 322 Mrd | |
+9,64% | 297 Mrd | |
+14,15% | 240 Mrd | |
+3,11% | 224 Mrd | |
+16,98% | 223 Mrd | |
+12,87% | 173 Mrd |
- Borsa valori
- Azioni
- Azione PRGO
- Azione PRGO
- Società Perrigo Company plc